Big Law

Judge Dismisses Shareholder Action Over Pharma’s Marketing of Opioid

A New York District judge granted pharmaceutical company Alkermes PLC’s motion to dismiss a shareholder class action alleging the company misrepresented sales figures and comparative effectiveness for a drug developed to treat opioid dependence.

Read the source article at Homepage

Leave a Review or Comment

Your email address will not be published. Required fields are marked *

Back to top button